Is Illumina Stock a Buy at Nearly 40 Times Earnings? 1 Analyst Thinks So

Every day, Wall Street analysts upgrade some stocks, downgrade others, and "initiate coverage" on a few more. But do these analysts even know what they're talking about? Today, we're taking one high-profile Wall Street pick and putting it under the microscope...

2017 has been a good year for owners of Illumina (NASDAQ: ILMN) stock. Shares of the genetic testing equipment maker are up nearly 50% since the year began, and received a healthy 14% bump in stock price after reporting fiscal second-quarter earnings last week.

But one analyst thinks Illumina could go up even more. Here are three things you need to know about that.

Source: Fool.com

Illumina Inc. Aktie

Illumina Inc. muss heute herbe Verluste wegstecken. Die Aktie notiert im Vergleich zu gestern um -5,59 % tiefer.
Die Community bevorzugt Illumina Inc., mit deutlich mehr Buy- (27) als Sell-Einschätzungen (4).
Ein Kursziel von 162 € für Illumina Inc. würde eine Steigerung von mehr als 50% gegenüber dem aktuellen Kurs von 107.86 € bedeuten.

Like: 0

ILMN

Teilen